Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00448175 · ClinicalTrials.gov registry record · Phase 4

Overactive Bladder Innovative Therapy Trial (OrBIT)

A Phase 4 study of Overactive Bladder, sponsored by Uroplasty.

Completed
Registry status
Phase 4
Development phase
100
Enrollment target
1
Study location

NCT00448175 is a Phase 4 study of Overactive Bladder that has completed, run by Uroplasty. The registered enrollment target is 100 participants, below the 209-participant average among 45 other Overactive Bladder trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00448175, a Phase 4 study of Overactive Bladder, has completed, sponsored by Uroplasty.

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare percutaneous tibial nerve stimulation (PTNS) to drug therapy for the treatment of symptoms of overactive bladder (OAB).

Conditions Studied

Overactive Bladder

Interventions

  • DEVICE Urgent PC Neuromodulation System
  • DRUG Tolterodine

Study Locations (1)

Minnesota

  • Uroplasty, Inc - Minnetonka

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2006-06
Est. Completion 2008-10
Phase Phase 4

Sponsor

Uroplasty

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00448175

The ClinicalTrials.gov registry entry for NCT00448175 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 209-participant average among 45 other Overactive Bladder trials with a reported enrollment target (52% lower). The listed sponsor is Uroplasty, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which Urgent PC Neuromodulation System is the first listed.

NCT00448175 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT00448175 about?

NCT00448175 is a clinical study titled "Overactive Bladder Innovative Therapy Trial (OrBIT)". The purpose of this study is to compare percutaneous tibial nerve stimulation (PTNS) to drug therapy for the treatment of symptoms of overactive bladder (OAB).

What is the current status of trial NCT00448175?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2006-06. Estimated completion is 2008-10.

What conditions does trial NCT00448175 study?

This clinical trial studies the following conditions: Overactive Bladder.

What interventions are being tested in trial NCT00448175?

The interventions under investigation include: Urgent PC Neuromodulation System (DEVICE), Tolterodine (DRUG).

Who is sponsoring clinical trial NCT00448175?

This trial is sponsored by Uroplasty, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00448175 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Overactive Bladder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Overactive Bladder

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.